Pharmaceuticals are back in the Game for OSA Treatment: Highlights from the 2019 American Thoracic Society (ATS) Conference in Dallas, Texas, and 2019 Affiliated Professional Sleep Societies Meeting (APSS) in San Antonio, Texas

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Sleep & breathing 2019-12, Vol.23 (4), p.1299-1300
Hauptverfasser:	Netzer, Nikolaus, Netzer, Petra G., Hanika, Kilian S., Pramsohler, Stephan, Eliasson, Arn H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetazolamide - therapeutic use Arousal - drug effects Attention - drug effects Blood Pressure - drug effects Carbon Dioxide - blood Continuous Positive Airway Pressure Dentistry Humans Internal Medicine Medicine Medicine & Public Health Neurology Otorhinolaryngology Oxygen - blood Pediatrics Pneumology/Respiratory System Polysomnography - drug effects Psychomotor Performance - drug effects Randomized Controlled Trials as Topic Respiration - drug effects Sleep Apnea, Central - drug therapy Sleep Apnea, Obstructive - drug therapy Sleep Breathing Physiology and Disorders • Conference Report Societies, Medical Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!